Max Healthcare Institute Limited reported a 22% increase in Profit After Tax (PAT) to INR 1,631 crore for the financial year ended March 31, 2026, compared to INR 1,336 crore in the previous year. The Network delivered its 22nd consecutive quarter of year-on-year growth, with Q4 FY26 PAT reaching INR 387 crore. The company announced these results during its earnings conference call held on May 22, 2026.

Financial Performance

The Network gross revenue for FY26 stood at INR 10,538 crore, reflecting a 16% year-on-year growth. For the quarter ended March 31, 2026, gross revenue increased by 10% year-on-year to INR 2,664 crore. Operating EBITDA for the full year grew by 14% to INR 2,638 crore, with a margin of 26.2%. In Q4, operating EBITDA was INR 682 crore, an 8% year-on-year increase.

Operational Highlights

Average occupancy for the Network remained above 75% despite an increase in operational bed capacity. Occupied bed days (OBDs) grew by 8% year-on-year and 4% quarter-on-quarter. The Average Revenue Per Occupied Bed (ARPOB) for Q4 stood at INR 77,900. International patient revenue was INR 227 crore, accounting for 9% of hospital revenue, while digital revenue contributed INR 838 crore, or 31% of overall revenue.

Expansion and Acquisition Updates

The company completed the acquisition of a controlling stake in Kalinga Hospital Limited, marking its entry into Eastern India. The Board approved an investment of INR 1,400 crore for a new 700-bed greenfield hospital in Lucknow. Expansion projects include a 500-bed hospital in Sector 56 Gurgaon, targeted for commissioning by the end of the year, and capacity additions in Mohali, Nanavati, and Max Smart.

The disclosure was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transcript of the earnings call is available on the company's website.

Max Healthcare Institute Limited has scheduled a series of investor conferences with Citi and Jefferies for June 2026. The Chairman and Managing Director and Senior Management of the company will participate in these meetings to engage with investors. The company confirmed that no unpublished price sensitive information will be disclosed during the conferences.

Conference Schedule

The investor conferences are organized under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule includes physical meetings in Mumbai and New York.

Key Disclosures

The company stated that the schedule is subject to changes due to exigencies on the part of the investors or the company. The disclosure was made by Dhiraj Aroraa, SVP - Company Secretary and Compliance Officer. This information has been hosted on the company's website.